GFAP Expression as an Indicator of Disease Severity in Mouse Models of Alexander Disease

ASN Neuro - United Kingdom
doi 10.1042/an20130003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Methemoglobin Level as an Indicator for Disease Severity in Sepsis

Critical Care
Critical CareIntensive Care Medicine
2008English

Author Correction: Serum GFAP as a Biomarker for Disease Severity in Multiple Sclerosis

Scientific Reports
Multidisciplinary
2019English

Total Protein Concentration of Gingival Crevicular Fluid as an Indicator of the Severity of Periodontal Disease.

Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology)
1991English

Increased Expression of miRNA-146a in Alzheimer's Disease Transgenic Mouse Models

Neuroscience Letters
Neuroscience
2011English

Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease

Journal of Neuroscience
Neuroscience
2012English

Identification of a Novel Nonsense Mutation in the Rod Domain of GFAP That Is Associated With Alexander Disease

European Journal of Human Genetics
Genetics
2014English

Gait Variability as Digital Biomarker of Disease Severity in Huntington’s Disease

Journal of Neurology
Neurology
2020English

Transgenic Mouse Models of Alzheimer's Disease

Biochemical Society Transactions
Biochemistry
1998English

Genetically Engineered Mouse Models of Parkinson's Disease

Brain Research Bulletin
Neuroscience
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy